Literature DB >> 7035012

Evidence against an interaction of angiotensin II with the sympathetic nervous system in man.

M G Nicholls, E A Espiner, K D Miles, A J Zweifler, S Julius.   

Abstract

Animal experiments indicate that angiotensin II can, under some circumstances stimulate the sympathetic nervous system at a number of different sites. In order to determine whether such a relationship of the renin-angiotensin and sympathetic nervous system exists in man, we increased (by intravenous infusion), or decreased (by administering the oral converting enzyme inhibitor captopril) circulating angiotensin II levels and monitored plasma adrenaline and noradrenaline responses. Angiotensin II infusions did not increase plasma catechol-amines, and lowering of angiotensin II by captopril treatment in patients with severe hypertension or congestive heart failure failed to alter plasma adrenaline or nor-adrenaline levels. Whether physiological levels of angiotensin II are capable of interacting directly with the sympathetic nervous system in man remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7035012     DOI: 10.1111/j.1365-2265.1981.tb00684.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  The effect of angiotensin II on endogenous noradrenaline release in man.

Authors:  P H Seidelin; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

2.  Neurotransmission in pig renal artery: the actions of angiotensin II and dopamine.

Authors:  D R Ferguson; M D Randall
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

Review 3.  The renin-angiotensin system in the control of systemic arterial pressure.

Authors:  A B Ribeiro; O Kohlmann; M A Saragoça; O Marson; O L Ramos
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.